Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection.
• To assess clinical and microbiological efficacy of FOM in patients with bacterial infection.
- To determine the rate and severity of unexpected adverse events.
- To determine the mean duration of therapy with FOM in patients with bacterial infection.
Multi-center, non-interventional study
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection|
|Study Start Date:||August 2010|
All Patients with bacterial infection receiving fosfomycin may be included
Please refer to this study by its ClinicalTrials.gov identifier: NCT01173575
|Contact: Christian Putensen, Prof., MD||+49-228 287 ext email@example.com|
|Contact: Freyja Maria Jüttner-Smolle, Prof., MD||+43-316 385 ext firstname.lastname@example.org|
|Medical University Graz||Completed|
|Graz, Styria, Austria, 8035|
|Heart and Diabetes Center North Rhine-Westphalia||Recruiting|
|Bad Oeynhausen, Germany, 32545|
|Contact: Jan Weile, MD +49 (0) 5731/97-3646 email@example.com|
|University of Bonn||Recruiting|
|Bonn, Germany, 53127|
|Contact: Christian Putensen, Prof., MD +49-228 287-14118 firstname.lastname@example.org|
|University Hospital Muenster||Recruiting|
|Muenster, Germany, 48149|
|Contact: Björn Ellger, Prof., MD +49 (0)251 / 83 - 4 72 69 email@example.com.-de|